Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 15 Show results per page	View Search Criteria \| Help With Results


1.		Phase III Study of Gemcitabine Compared With UFT in Patients With Completely Resected Pathological Stage IB-IIIa Non Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 75				Other				WJTOG0101 NCT00139971


2.		Randomized Phase III Adjuvant Study for Stage III Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 80				Other				HGCSG-CAD NCT00209742


3.		Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 80				Other				CPP276 NCT00207831


4.		UFT/LV Maintenance Vs Observation in Metastatic Breast Cancer Responsive to Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Over 18				Other				AERO-MB02 NCT00189631

Last Modified: 9/11/2008 First Published: 6/9/2006


5.		Phase III Randomized Study of Adjuvant Chemotherapy Comprising S-1 Versus Tegafur-Uracil (UFT) in Patients With Definitively Treated Stage III or IV Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 75				Other				YCU-BRI-HN-05-01 NCT00336947

Last Modified: 9/11/2008 First Published: 10/21/2006


6.		Phase III Randomized Study of Adjuvant Tegafur-Uracil Versus Observation Only in Patients With Curatively Resected Stage II Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 80				Other				TMDU-BRI-CC-05-01 NCT00392899


7.		A Phase III Trial Comparing UFT+PSK to UFT+LV in Stage IIB, III Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 80				Other				MCSGO-CCTG-0501 NCT00385970


8.		Uracil and Tegafur/Leucovorin (UFT/LV) Versus UFT/LV+ Polysaccharide-K (PSK) for Stage IIIa/IIIb Colorectal Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				20 to 79				Other				ICOG-CC01 NCT00497107

Last Modified: 9/15/2008 First Published: 4/15/2008


9.		Phase III Randomized Study of Adjuvant Tegafur-Uracil and Leucovorin Calcium Versus S-1 in Patients With Resected Stage III Colon Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Biomarker/Laboratory analysis, Treatment				Active				20 to 80				Other				TMDU-TRICC0706 TRICC0706, NCT00660894


10.		A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				Other				FEMH-94037 NCT00384800

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute